What causes cgrp

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 4, 2026

Quick Answer: Calcitonin gene-related peptide (CGRP) is a neuropeptide that plays a significant role in the development of migraine headaches. It is released in the trigeminal nerve system and is thought to cause vasodilation (widening of blood vessels) and inflammation, contributing to the throbbing pain and other symptoms associated with migraines.

Key Facts

What is Calcitonin Gene-Related Peptide (CGRP)?

Calcitonin gene-related peptide (CGRP) is a neuropeptide, which is a small protein molecule that acts as a messenger in the nervous system. It is widely distributed throughout the body, with significant concentrations found in the brain and peripheral nervous system, particularly within the trigeminovascular system. This system is a network of nerves and blood vessels in the head that is critically involved in the sensation of pain, especially facial pain and headaches.

The Role of CGRP in Migraine Pathophysiology

For many years, theories about migraine focused on blood vessel changes, such as constriction and dilation. However, research over the past few decades has highlighted the central role of CGRP in the development of migraine headaches. It is now understood that CGRP is not merely a bystander but an active participant in the migraine process.

CGRP Release During Migraine Attacks

During a migraine attack, there is a significant release of CGRP from the trigeminal nerve endings that innervate cranial blood vessels. This release is thought to be triggered by various factors that can initiate a migraine, although the precise triggers are still being investigated. Once released, CGRP exerts its effects on surrounding tissues.

Mechanisms of Action of CGRP

CGRP has several key effects that contribute to migraine symptoms:

Evidence Supporting CGRP's Role

A substantial body of evidence supports CGRP's involvement in migraines:

CGRP and Migraine Treatment

The understanding of CGRP's role has revolutionized migraine treatment. Two main classes of drugs have been developed:

1. CGRP Antagonists (Gepants)

These are oral medications that block the CGRP receptor, preventing CGRP from binding and exerting its effects. Gepants can be used both for the acute treatment of migraine attacks and, in some cases, for migraine prevention. Examples include ubrogepant and rimegepant.

2. CGRP Monoclonal Antibodies

These are injectable medications that target either the CGRP molecule itself (preventing it from binding to its receptor) or the CGRP receptor. They are primarily used for migraine prevention and are typically administered monthly or quarterly. Examples include erenumab, fremanezumab, and galcanezumab.

These targeted therapies represent a significant advancement over older migraine medications that often had broader mechanisms of action and more side effects. By specifically targeting the CGRP pathway, these drugs offer a more precise approach to managing migraine pain.

Beyond Migraine: Other Potential Roles of CGRP

While CGRP is most extensively studied for its role in migraine, it also has other physiological functions. It is involved in regulating blood pressure, heart rate, and gastrointestinal motility. It also plays a role in bone metabolism and wound healing. However, its contribution to pain pathways, particularly in the context of headache disorders, remains its most clinically significant and well-researched function.

Sources

  1. Calcitonin gene-related peptide - WikipediaCC-BY-SA-4.0
  2. Migraine treatment: Beyond over-the-counter drugs - Mayo Clinicfair-use
  3. CGRP and Migraine - PubMed Centralfair-use

Missing an answer?

Suggest a question and we'll generate an answer for it.